Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer

Clinical trial NCT02103062 · COMPLETED

Trial details

NCT number: NCT02103062
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2014-05-05
Primary completion: 2014-11-10
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.